Items Tagged ‘Stage I/Smoldering Myeloma Multiple Myeloma’

December 31st, 2015

Leukemia and Lymphoma Society Summarizes Major Advances in Treatment of Blood Cancers Presented at American Society of Hematology Meetings

By

For the more than one million Americans living with or in remission from a blood cancer, there is more hope than ever for new treatments and even cures—not someday, but today. Clinical findings presented at the 57th American Society of Hematology (ASH) Annual Meeting, in Orlando, December 5-8, made it increasingly clear that new discoveries […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, all, AML, ASH, blood cancer, CAR T, Chronic Lymphocytic Leukemia, CLL, fda, Leukemia, Lymphoma


December 8th, 2014

Investigational Oral Drug Combo Shows Promise for Newly Diagnosed Multiple Myeloma

By

Doctors have reported that the investigational drug ixazomib which can be taken orally in combination with Revlimid (lenalidomide) and dexamethasone shows promise for the treatment of patients with newly diagnosed multiple myeloma, according to the results of a study published in The Lancet Oncology. Multiple myeloma is a cancer of plasma cells. Plasma cells are a special […]

View full entry

Tags: ixazomib, Multiple Myeloma, News, revlimid, Stage I/Smoldering Myeloma Multiple Myeloma, Stages II-III Multiple Myeloma


March 7th, 2014

Revlimid Linked with Second Primary Malignancies in Patients with Myeloma

By

Revlimid® (lenalidomide)—particulary when used in combination with oral melphalan—is associated with an increased risk of second primary malignancies in patients with myeloma, according to the results of a study published in The Lancet Oncology. Multiple myeloma is a cancer of plasma cells (white blood cells that produce antibodies). In 2013, there were an estimated 22,350 new […]

View full entry

Tags: Multiple Myeloma, News, Stage I/Smoldering Myeloma Multiple Myeloma, Stages II-III Multiple Myeloma


August 30th, 2013

Early Treatment of Multiple Myeloma Slows Progression

By

Early treatment with Revlimid® (lenalidomide) and dexamethasone for patients with high-risk smoldering multiple myeloma delays progression to active disease and increases overall survival, according to the results of a study published in the New England Journal of Medicine. Multiple myeloma is a cancer of plasma cells, which are a special type of white blood cell […]

View full entry

Tags: Multiple Myeloma, News, Stage I/Smoldering Myeloma Multiple Myeloma


March 13th, 2012

Carfilzomib Promising in Newly Diagnosed Multiple Myeloma

By

The investigational drug carfilzomib, in combination with Revlimid® (lenalidomide) and low-dose dexamethasone, produced high response rates in patients with newly diagnosed myeloma. The results of this Phase I/II clinical trial were presented at the 2011 annual meeting of the American Society of Hematology. Multiple myeloma is a cancer of plasma cells, which are a special […]

View full entry

Tags: Multiple Myeloma, News, Stage I/Smoldering Myeloma Multiple Myeloma, Stages II-III Multiple Myeloma


March 5th, 2010

Benefit of Velcade on Myeloma Survival Added to Prescribing Information

By

The U.S. Food and Drug Administration (FDA) has approved expanded prescribing information for Velcade® (bortezomib). Velcade’s label now includes results from the VISTA study, which show that Velcade improves long-term overall survival among patients with previously untreated multiple myeloma. Multiple myeloma is a cancer of plasma cells. Plasma cells are a special type of white […]

View full entry

Tags: Multiple Myeloma, News, Stage I/Smoldering Myeloma Multiple Myeloma, Stages II-III Multiple Myeloma


January 16th, 2008

Additional Evidence Shows Thalomid® Improves Survival in Elderly with Multiple Myeloma

By

Additional Evidence Shows Thalomid® Improves Survival in Elderly with Multiple Myeloma According to results recently presented at the 2007 annual meeting of the American Society of Hematology, additional evidence confirms that the addition of Thalomid® (thalidomide) to Alkeran® (melphalan) and prednisone improves survival in elderly patients with multiple myeloma. Multiple myeloma is a cancer of […]

View full entry

Tags: News, Stage I/Smoldering Myeloma Multiple Myeloma, Stages II-III Multiple Myeloma